Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Does a Magnetic Resonance-Only Pathway Impact Dosimetric and Acute Clinical Outcomes in Prostate Stereotactic Ablative Body Radiotherapy?

Created on 12 Nov 2026

Authors

J J Wyatt, A Eassom, S West, R L Brooks-Pearson, N Richmond, B Ormston, R Chandler, J Frew, X Jiang, R A Pearson

Published in

Clinical oncology (Royal College of Radiologists (Great Britain)). Pages 104356. Oct 14, 2026. Epub Oct 14, 2026.

Abstract

This study aimed to compare prostate target and organs at risk (OAR) volumes, doses, and acute toxicity scores for patients treated with prostate stereotactic ablative body radiotherapy (SABR) using magnetic resonance (MR)-only or MR registered with computed tomography (MR-CT) pathways.
A total of 486 patients prescribed 36.25 Gy in five fractions were included. Patients were treated using a. MR-CT (January-October 2024, n = 262) or MR-only (October 2024-August 2025, n = 222) pathway. Unfavourable risk patients (36% MR-only, 37% MR-CT) received additional hormone therapy. Sixty-five percent of MR-only patients and 76% of MR-CT patients attended an acute toxicity assessment two weeks post treatment using Common Toxicity Criteria. Prostate, bladder, penile bulb, and rectum volumes and dose constraints were compared between the two pathways using the Mann-Whitney U-test. The proportion of patients reporting acute toxicity of grade ≥1, ≥2, and ≥3 were compared.
Median MR-only prostate volumes were 38-9+10cm3 value to third quartile, -value to first quartile, compared to MR-CT volumes of 40-10+11cm3, a 4% reduction (P = .07). For unfavourable risk patients only, the reduction was 10%, 30-7+7 cm3 (MR-only) and 33-7+7 cm3 (MR-CT, P = .04). For both favourable and unfavourable risk patients, the penile bulb mean dose was 52% lower, 2.2 Gy (MR-only) compared to 4.6 Gy (MR-CT, P < .001). There was a reduction of -20.3% (95% confidence interval: -37.4%, -3.2%) in acute grade ≥1 and -21.7% (-39.4%, -3.7%) in grade ≥2 sexual toxicities in the MR-only cohort, although the sexual toxicity response rates were low.
MR-only prostate SABR significantly reduced penile bulb doses and may have reduced target volumes and acute sexual toxicity while enabling improved patient experience and departmental efficiency. These findings need to be validated in larger patient cohorts with longer-term follow-up.

PMID:
43015158
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement